Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-045110

CEO sold 2,216 shares at $2.18 ($4,826)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-18 Sale : show line 1 in the form −2,216 $2.18 $4,826 1,051,358 D
Open-market sales · 2,216 sh · avg $2.18 · $4,826
Loading xslF345X06/form4.xml…